EUCRISA Drug Profile: EUCRISA (crisaborole) drug patents, FDA exclusivity, litigation, drug prices

by DrugPatentWatch

EUCRISA Drug Profile, 2023

This report focuses on EUCRISA and covers the following critical aspects of this drug:

United States patentsDistrict Court patent litigationEuropean supplementary protection certificates (SPCs)Clinical trialsDrug pricesFinished product suppliersRaw active pharmaceutical ingredient (API) sourcesContentsProfile for EUCRISAUS PatentsUS Regulatory ExclusivityUS District Court LitigationInternational (exUS) PatentsSupplementary...

• Format: Paperback
• Language: English
• ISBN: B0CFCSY2Q8
• ISBN13: 9798857056684
• Release Date: August 2023
• Publisher: Independently Published
• Length: 68 Pages
• Weight: 0.40 lbs.
• Dimensions: 0.1" x 8.5" x 11.0"